0001104659-22-070674.txt : 20220613
0001104659-22-070674.hdr.sgml : 20220613
20220613210747
ACCESSION NUMBER: 0001104659-22-070674
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220610
FILED AS OF DATE: 20220613
DATE AS OF CHANGE: 20220613
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Miller Steven Clive
CENTRAL INDEX KEY: 0001883325
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40825
FILM NUMBER: 221013259
MAIL ADDRESS:
STREET 1: C/O WARBY PARKER INC.
STREET 2: 233 SPRING STREET, 6TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10013
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Warby Parker Inc.
CENTRAL INDEX KEY: 0001504776
STANDARD INDUSTRIAL CLASSIFICATION: OPHTHALMIC GOODS [3851]
IRS NUMBER: 800423634
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 233 SPRING STREET
STREET 2: 6TH FLOOR EAST
CITY: NEW YORK
STATE: NY
ZIP: 10013
BUSINESS PHONE: (646) 847-7215
MAIL ADDRESS:
STREET 1: 233 SPRING STREET
STREET 2: 6TH FLOOR EAST
CITY: NEW YORK
STATE: NY
ZIP: 10013
FORMER COMPANY:
FORMER CONFORMED NAME: JAND, Inc.
DATE OF NAME CHANGE: 20101102
4
1
tm2218339-9_4seq1.xml
OWNERSHIP DOCUMENT
X0306
4
2022-06-10
0
0001504776
Warby Parker Inc.
WRBY
0001883325
Miller Steven Clive
C/O WARBY PARKER INC.,
233 SPRING STREET, 6TH FLOOR EAST
NEW YORK
NY
10013
0
1
0
0
Chief Financial Officer
Class A Common Stock
2022-06-10
4
M
0
12137
0
A
170506
D
Class A Common Stock
2022-06-10
4
S
0
5084
14.64
D
165422
D
Class A Common Stock
2022-06-13
4
S
0
7053
13.4217
D
158369
D
Restricted Stock Units
2022-06-10
4
M
0
1981
0
D
Class A Common Stock
1981
21131
D
Restricted Stock Units
2022-06-10
4
M
0
2525
0
D
Class A Common Stock
2525
16833
D
Restricted Stock Units
2022-06-10
4
M
0
2535
0
D
Class A Common Stock
2535
6759
D
Restricted Stock Units
2022-06-10
4
M
0
5096
0
D
Class A Common Stock
5096
64547
D
Includes 925 shares acquired on May 14, 2022 under the Issuer's employee stock purchase plan in an exempt transaction pursuant to Rule 16b-3(c).
These share sales are required by the Issuer's equity compensation plan to cover taxes due on restricted stock units ("RSUs") that vested.
The sales reported were effected pursuant to a 10b5-1 trading plan adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $13.13 to $14.04. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Each RSU represents a contingent right to receive one share of the Company's Class A Common Stock.
This filing relates to the occurrence of a RSU vesting event.
The RSUs will vest in 48 monthly installments beginning on January 1, 2021 and will expire on January 27, 2028.
The RSUs will vest in 48 monthly installments beginning on January 1, 2020 and will expire on November 19, 2026.
The RSUs will vest in 48 monthly installments beginning on January 1, 2019 and will expire on March 28, 2026.
The RSUs will vest in 48 monthly installments beginning on July 1, 2021 and will expire on June 14, 2031.
/s/ Hyung Bak, Attorney-in-Fact
2022-06-13